A Tanuri,P Swanson,S Devare et al.
A Tanuri et al.
The prevalence of HIV infection in Brazil is one of the highest in the world. In addition, transfusion-transmitted HIV accounts for 2.3% of all AIDS cases in Brazil. The objective of this study was to evaluate genetic diversity and distribu...
T E Taha,R H Gray,N I Kumwenda et al.
T E Taha et al.
Disturbances of vaginal flora are common among women of reproductive age. In areas of sub-Saharan Africa where the prevalence of HIV is high, the frequency of bacterial vaginosis (BV) is also high. In this study, we assessed the association...
Short-term effects of large-dose vitamin A supplementation on viral load and immune response in HIV-infected women [0.03%]
大剂量维生素A补充对感染人类免疫缺陷病毒妇女的病毒负荷和免疫反应的短期影响
J H Humphrey,T Quinn,D Fine et al.
J H Humphrey et al.
Vitamin A supplementation has been suggested for treatment and prevention of HIV infection. However, some in vitro data indicate that vitamin A may activate HIV. Randomly, 40 HIV-seropositive women of reproductive age were allocated to rece...
Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex [0.03%]
未能在HIV-1感染者(伴有和不伴有艾滋病痴呆综合症)的脑脊液中检测到奈非那韦
F Aweeka,A Jayewardene,S Staprans et al.
F Aweeka et al.
Objective: To assess the penetration of the HIV-1 protease inhibitor, nelfinavir, into cerebrospinal fluid (CSF). Design: Nelfinavir, a...
Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS [0.03%]
抗巨细胞病毒药物对艾滋病患者既往确诊的卡波西肉瘤病程的影响
R Robles,D Lugo,L Gee et al.
R Robles et al.
Objective: To evaluate the association of ganciclovir (GCV) and foscarnet (PFA) therapy with the outcome of previously diagnosed Kaposi's sarcoma (KS) after initiating antiviral therapy for cytomegalovirus (CMV) end-organ...
Protease inhibitor-based therapy is associated with decreased HIV-related health care costs in men treated at a Veterans Administration hospital [0.03%]
在退伍军人事务管理局医院接受治疗的男性中，基于蛋白酶抑制剂的疗法与降低的HIV相关医疗费用有关
P Keiser,M B Kvanli,D Turner et al.
P Keiser et al.
Background: Protease inhibitor (PI) therapy for HIV infection is associated with decreased rates of opportunistic infections and death. Statistical models predict that decreased complications will be associated with decre...
Concomitant therapy with subcutaneous interleukin-2 and zidovudine plus didanosine in patients with early stage HIV infection [0.03%]
早期HIV感染患者皮下注射干扰素-2和齐多夫定加叠诺的联合疗法
C Simonelli,S Zanussi,S Sandri et al.
C Simonelli et al.
A phase II study was performed to evaluate the feasibility and activity of subcutaneous (SC) interleukin-2 (IL-2) administration plus zidovudine (ZDV) and didanosine (ddI) in patients with early stage HIV infection. Between October 1995 and...
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease [0.03%]
一项有关奈韦拉平用于初治晚期艾滋病病毒感染者抗病毒治疗的随机、双盲临床试验
M Floridia,R Bucciardini,D Ricciardulli et al.
M Floridia et al.
The immunologic and virologic activity of nevirapine in combination with two nucleosides (zidovudine [ZDV] and didanosine [ddI]) was evaluated in antiretroviral-naive patients with a CD4 count
Comparison of HTLV-I basal transcription and expression of CREB/ATF-1/CREM family members in peripheral blood mononuclear cells and Jurkat T cells [0.03%]
外周血单个核细胞与Jurkat T 细胞HTLV-I基础转录及CREB/ATF-1/CREM家族成员表达的比较分析研究
G C Newbound,J P O&#x;Rourke,N D Collins et al.
G C Newbound et al.
HTLV-I is the etiologic agent of adult T-cell leukemia/lymphoma and is associated with tropical spastic paraparesis/HTLV-I-associated myelopathy. Following integration into the host cell genome, HTLV-I replication is regulated by both host ...
HTLV-I/II antibodies among three different Indian groups from Paraguay [0.03%]
巴拉圭三个不同印度人群中的人类T细胞白血病病毒I型和II型抗体
M B de Cabral,M E Vera,M Samudio et al.
M B de Cabral et al.